RenovoRx Inc. (RNXT)
NASDAQ · Healthcare
RenovoRx Inc. Operating Income 2024–2025
RenovoRx Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- RenovoRx Inc. operating income for the quarter ending March 31, 2026 was -3.5 M, a 11.54% increase year-over-year.
- RenovoRx Inc. operating income for the twelve months ending March 31, 2026 was -12.5 M.
- RenovoRx Inc. annual operating income for 2025 was -12.5 M, a 14.04% increase from 2024.
- RenovoRx Inc. annual operating income for 2024 was -11.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
RenovoRx Inc. Operating Income — FAQ
RenovoRx Inc. (RNXT) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is RenovoRx Inc.'s operating income?
RenovoRx Inc. (RNXT) reported operating income of -$13M for fiscal 2025.
Where can I see RNXT's operating income history?
The chart and table above show RenovoRx Inc.'s operating income by year and by quarter, including the growth rate.